412 related articles for article (PubMed ID: 30031695)
1. Using the Human Factors Framework to understand the origins of medication safety problems in community pharmacy: A qualitative study.
Al Juffali L; Al-Aqeel S; Knapp P; Mearns K; Family H; Watson M
Res Social Adm Pharm; 2019 May; 15(5):558-567. PubMed ID: 30031695
[TBL] [Abstract][Full Text] [Related]
2. Medication safety problems priorities in community pharmacy in Saudi Arabia: a multi-stakeholder Delphi study using the human factors framework.
Al Juffali LA; Knapp P; Al-Aqeel S; Watson MC
BMJ Open; 2019 Nov; 9(11):e032419. PubMed ID: 31694852
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
4. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
[TBL] [Abstract][Full Text] [Related]
5. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
[TBL] [Abstract][Full Text] [Related]
6. Communication needs of patients with altered hearing ability: Informing pharmacists' patient care services through focus groups.
Ferguson M; Liu M
J Am Pharm Assoc (2003); 2015; 55(2):153-60. PubMed ID: 25700133
[TBL] [Abstract][Full Text] [Related]
7. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
[TBL] [Abstract][Full Text] [Related]
8. Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.
Boyle TA; Bishop AC; Duggan K; Reid C; Mahaffey T; MacKinnon NJ; Mahaffey A
Res Social Adm Pharm; 2014; 10(1):45-57. PubMed ID: 23528447
[TBL] [Abstract][Full Text] [Related]
9. Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in New Delhi, India.
Kotwani A; Wattal C; Joshi PC; Holloway K
J Clin Pharm Ther; 2012 Jun; 37(3):308-12. PubMed ID: 21883328
[TBL] [Abstract][Full Text] [Related]
10. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
11. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy.
Nusair MB; Guirguis LM
Res Social Adm Pharm; 2017; 13(2):349-357. PubMed ID: 27102265
[TBL] [Abstract][Full Text] [Related]
12. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
[TBL] [Abstract][Full Text] [Related]
13. Do no harm: the role of community pharmacists in regulating public access to prescription drugs in Saudi Arabia.
Bahnassi A
Int J Pharm Pract; 2016 Apr; 24(2):142-5. PubMed ID: 26383607
[TBL] [Abstract][Full Text] [Related]
14. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
Svensberg K; Sporrong SK; Björnsdottir I
Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
[TBL] [Abstract][Full Text] [Related]
15. [IPADAM quali study. Intervention of the Pharmacist in the Issue of Self-medication: Experience of pharmacy team focus groups and patients' perceptions].
Savanovitch C; Bedhomme S; Van Lander A; Prunet-Spano C; Vennat B
Ann Pharm Fr; 2018 Sep; 76(5):399-407. PubMed ID: 29801716
[TBL] [Abstract][Full Text] [Related]
16. Public attitudes towards community pharmacy in Arabic speaking Middle Eastern countries: A systematic review.
El Hajj MS; Mekkawi R; Elkaffash R; Saleh R; El Awaisi A; Wilbur K
Res Social Adm Pharm; 2021 Aug; 17(8):1373-1395. PubMed ID: 33257161
[TBL] [Abstract][Full Text] [Related]
17. Australian mental health consumers and carers expect more health management information from community pharmacy.
Fejzic J; Knox K; Hattingh HL; Mey A; McConnell D; Wheeler AJ
Int J Pharm Pract; 2017 Dec; 25(6):454-462. PubMed ID: 28303618
[TBL] [Abstract][Full Text] [Related]
18. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
Sato N; Fujita K; Kushida K; Chen TF
Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the current practice of self-medication consultations in Eastern Indonesian community pharmacies: a qualitative study.
Brata C; Fisher C; Marjadi B; Schneider CR; Clifford RM
BMC Health Serv Res; 2016 May; 16():179. PubMed ID: 27178346
[TBL] [Abstract][Full Text] [Related]
20. Patient-perceived barriers and facilitators to the implementation of a medication review in primary care: a qualitative thematic analysis.
Uhl MC; Muth C; Gerlach FM; Schoch GG; Müller BS
BMC Fam Pract; 2018 Jan; 19(1):3. PubMed ID: 29304725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
